Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, discusses Rucaparib, Niraparib, and Olaparib all Show Benefit. Differences between the drugs, are in their toxicities.
Rucaparib, Niraparib, and Olaparib all Show Benefit Differences between the drugs, are in their toxicities
